Clinical Trial Update: Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a low-cost HRME device for early diagnosis of esophageal adenocarcinoma in Barrett's Esophagus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma

Snippet

Sponsor: Anandasabapathy, Sharmila, M.D. | Conditions: Barrett's Esophagus | Phase 2 | Status: UNKNOWN